logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Xima Medical (03309.HK) spent HKD 668,400 on June 2nd to repurchase 400,000 shares.

date
04/06/2025
WISDOM FINANCIAL APP News, HEMA Medical (03309.HK) announced that on June 2, 2025, the company spent 668,400 Hong Kong dollars to repurchase 400,000 shares.
Latest
2 m ago
Wanto Smart Control stated on the investor interaction platform that the company's products are not currently being used on drones.
6 m ago
Domestic chip design software leader launches a technological counterattack: Hejian Software announces free trial of key EDA software.
7 m ago
Regulations for the implementation of road testing and demonstration applications of smart connected vehicles in Hunan Xiangjiang New Area released, accelerating the development of intelligent connected vehicle industry in Changsha.
8 m ago
Japanese central bank official: With the cashless society trend, Japan must pursue payment innovation.
10 m ago
Prices have skyrocketed, who is the king of strategic metals in A-shares?
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.